332 | Humans |
302 | Parkinson Disease |
217 | Male |
205 | Middle Aged |
204 | Female |
185 | Aged |
107 | Adult |
51 | Antiparkinson Agents |
47 | Aged, 80 and over |
42 | Levodopa |
40 | Treatment Outcome |
40 | Severity of Illness Index |
35 | Follow-Up Studies |
35 | Double-Blind Method |
31 | Genetic Predisposition to Disease |
26 | Mutation |
26 | Brain |
25 | Risk Factors |
24 | Genotype |
24 | Animals |
24 | Age of Onset |
23 | Tremor |
23 | Movement Disorders |
23 | Essential Tremor |
23 | Disease Progression |
22 | Dopamine Agonists |
21 | Time Factors |
21 | Neuroprotective Agents |
20 | Diagnosis, Differential |
20 | Cohort Studies |
19 | Neuropsychological Tests |
19 | Nerve Tissue Proteins |
19 | Globus Pallidus |
19 | Dopamine |
19 | Case-Control Studies |
18 | Prospective Studies |
18 | Polymorphism, Single Nucleotide |
18 | Neurologic Examination |
18 | Adolescent |
17 | United States |
16 | Parkinson Disease, Secondary |
16 | Dystonia |
16 | Deep Brain Stimulation |
16 | DNA Mutational Analysis |
15 | Retrospective Studies |
15 | Gene Frequency |
14 | Dyskinesia, Drug-Induced |
14 | Dose-Response Relationship, Drug |
13 | Genetic Variation |
13 | Disability Evaluation |
13 | Cognition Disorders |
13 | Clinical Trials as Topic |
12 | alpha-Synuclein |
12 | Predictive Value of Tests |
12 | Neurons |
12 | Biomarkers |
12 | Age Factors |
11 | Protein-Serine-Threonine Kinases |
11 | Polymorphism, Genetic |
11 | Longitudinal Studies |
11 | Alzheimer Disease |
11 | Activities of Daily Living |
10 | Surveys and Questionnaires |
10 | Supranuclear Palsy, Progressive |
10 | Posture |
10 | Magnetic Resonance Imaging |
10 | Haplotypes |
10 | Gait |
9 | Transcription Factors |
9 | Thiophenes |
9 | Tetrahydronaphthalenes |
9 | Quality of Life |
9 | Pergolide |
9 | Pedigree |
9 | Genetic Testing |
9 | Functional Laterality |
9 | Basal Ganglia |
9 | Alleles |
8 | Subthalamic Nucleus |
8 | Sex Factors |
8 | Movement |
8 | Gait Disorders, Neurologic |
8 | European Continental Ancestry Group |
8 | Drug Therapy, Combination |
8 | Drug Administration Schedule |
8 | Carbidopa |
8 | Benzothiazoles |
8 | Administration, Cutaneous |
7 | Thiazoles |
7 | Substantia Nigra |
7 | Selegiline |
7 | Randomized Controlled Trials as Topic |
7 | Phenotype |
7 | Nerve Degeneration |
7 | Multiple System Atrophy |
7 | Motor Activity |
7 | Antipsychotic Agents |
6 | tau Proteins |
6 | Young Adult |
6 | Ubiquitin-Protein Ligases |
6 | Stereotaxic Techniques |
6 | Sensitivity and Specificity |
6 | Risk |
6 | Reverse Transcriptase Polymerase Chain Reaction |
6 | Reproducibility of Results |
6 | Receptors, Dopamine |
6 | Proportional Hazards Models |
6 | Postural Balance |
6 | Postoperative Complications |
6 | Polymerase Chain Reaction |
6 | Odds Ratio |
6 | Nuclear Receptor Subfamily 4, Group A, Member 2 |
6 | Intracellular Signaling Peptides and Proteins |
6 | Dominance, Cerebral |
6 | Dementia |
6 | DNA-Binding Proteins |
6 | Comorbidity |
5 | Tomography, X-Ray Computed |
5 | Syndrome |
5 | Prevalence |
5 | Peptide Fragments |
5 | Pallidotomy |
5 | Motor Skills |
5 | Mice |
5 | Indans |
5 | Huntington Disease |
5 | Genetic Association Studies |
5 | Ergolines |
5 | Electrodes, Implanted |
5 | Electric Stimulation Therapy |
5 | Drug Combinations |
5 | Depression |
5 | Cross-Sectional Studies |
5 | Child |
5 | Cell Line, Tumor |
5 | Carrier Proteins |
5 | Apolipoproteins E |
5 | Amyloid beta-Peptides |
4 | Ventral Thalamic Nuclei |
4 | Statistics, Nonparametric |
4 | Single-Blind Method |
4 | Regression Analysis |
4 | Reference Values |
4 | Reaction Time |
4 | Putamen |
4 | Psychomotor Performance |
4 | Point Mutation |
4 | Placebos |
4 | Parkinsonian Disorders |
4 | Outcome Assessment (Health Care) |
4 | Neurodegenerative Diseases |
4 | Mice, Inbred C57BL |
4 | Mental Disorders |
4 | Membrane Proteins |
4 | Genome-Wide Association Study |
4 | Genetic Markers |
4 | Genetic Linkage |
4 | Family Health |
4 | Electric Stimulation |
4 | Early Diagnosis |
4 | Dopamine Plasma Membrane Transport Proteins |
4 | Depressive Disorder |
4 | Corpus Striatum |
4 | Cognition |
4 | Cell Survival |
4 | Cell Line |
4 | Canada |
4 | Blepharospasm |
4 | Atrophy |
4 | Analysis of Variance |
4 | Acetylcysteine |
3 | Vitamin E |
3 | Videotape Recording |
3 | Tyrosine 3-Monooxygenase |
3 | Tourette Syndrome |
3 | Tomography, Emission-Computed, Single-Photon |
3 | Tocopherols |
3 | Thalamus |
3 | Thalamic Nuclei |
3 | Synucleins |
3 | Signal Transduction |
3 | Sialorrhea |
3 | Risk Assessment |
3 | Receptors, Dopamine D2 |
3 | ROC Curve |
3 | Protein Kinases |
3 | Proteasome Endopeptidase Complex |
3 | Prognosis |
3 | Polymorphism, Single-Stranded Conformational |
3 | Peripheral Nerve Injuries |
3 | Ophthalmoplegia |
3 | Oncogene Proteins |
3 | Occupational Exposure |
3 | North America |
3 | Neoplasms |
3 | Myoclonus |
3 | Models, Genetic |
3 | Models, Animal |
3 | Microsatellite Repeats |
3 | Mental Processes |
3 | Memory Disorders |
3 | Membrane Transport Proteins |
3 | Membrane Glycoproteins |
3 | Logistic Models |
3 | Lod Score |
3 | Linkage Disequilibrium |
3 | Isoenzymes |
3 | Hand |
3 | Genetic Therapy |
3 | Exons |
3 | Europe |
3 | Dystonic Disorders |
3 | Drug Resistance |
3 | Disease Models, Animal |
3 | Diagnostic Imaging |
3 | DNA, Mitochondrial |
3 | Chromosome Mapping |
3 | Chi-Square Distribution |
3 | Catechol O-Methyltransferase Inhibitors |
3 | Bromocriptine |
3 | Blotting, Western |
3 | Base Sequence |
3 | Basal Ganglia Diseases |
3 | Autophagy |
3 | Autonomic Nervous System Diseases |
3 | Asian Continental Ancestry Group |
3 | Arm |
3 | Apomorphine |
3 | Antioxidants |
2 | Weight Loss |
2 | Wakefulness |
2 | Verbal Learning |
2 | Valproic Acid |
2 | Ubiquitin |
2 | Ubiquinone |
2 | Tunisia |
2 | Treatment Failure |
2 | Time |
2 | Tics |
2 | Tic Disorders |
2 | Tetrabenazine |
2 | Telephone |
2 | Statistics as Topic |
2 | Societies, Medical |
2 | Sleep Wake Disorders |
2 | Sleep Stages |
2 | Sirolimus |
2 | Serine |
2 | Serbia |
2 | Sequence Analysis, DNA |
2 | Rotenone |
2 | Restless Legs Syndrome |
2 | Reflex, Abnormal |
2 | Reflex Sympathetic Dystrophy |
2 | Receptors, Dopamine D3 |
2 | Random Allocation |
2 | Radiosurgery |
2 | Radiopharmaceuticals |
2 | RNA-Binding Proteins |
2 | RNA, Small Interfering |
2 | RNA, Messenger |
2 | Quality Control |
2 | Purines |
2 | Psychosurgery |
2 | Psychiatric Status Rating Scales |
2 | Proteasome Inhibitors |
2 | Propranolol |
2 | Positron-Emission Tomography |
2 | Pilot Projects |
2 | Physical Therapy Modalities |
2 | Physical Examination |
2 | Phosphorylation |
2 | Patient Selection |
2 | Patient Satisfaction |
2 | Oxygen Consumption |
2 | Open Reading Frames |
2 | Oligonucleotide Array Sequence Analysis |
2 | Occupational Diseases |
2 | Obsessive-Compulsive Disorder |
2 | Neurturin |
2 | Neurosurgical Procedures |
2 | Neuromuscular Diseases |
2 | Neurocognitive Disorders |
2 | Neural Pathways |
2 | Nervous System Diseases |
2 | Nausea |
2 | Multivariate Analysis |
2 | Motor Neurons |
2 | Monoamine Oxidase Inhibitors |
2 | Molecular Sequence Data |
2 | Mobility Limitation |
2 | Mitochondria |
2 | Microscopy, Electron |
2 | Microelectrodes |
2 | Mice, Knockout |
2 | Memory |
2 | Melanoma |
2 | Manganese |
2 | Manganese Poisoning |
2 | Locomotion |
2 | Linear Models |
2 | Ligases |
2 | Lewy Bodies |
2 | Leg |
2 | Iron |
2 | Iron Metabolism Disorders |
2 | Indoles |
2 | Incidence |
2 | Immunohistochemistry |
2 | Hypotension, Orthostatic |
2 | Homeodomain Proteins |
2 | Heart Rate |
2 | Hallucinations |
2 | H-Reflex |
2 | Glycine |
2 | Glutathione Transferase |
2 | Glucosylceramidase |
2 | Genetic Vectors |
2 | Genetic Loci |
2 | Gene Expression Regulation |
2 | Gene Dosage |
2 | Founder Effect |
2 | Fluorine Radioisotopes |
2 | Fetal Tissue Transplantation |
2 | Ferritins |
2 | Feasibility Studies |
2 | Exercise |
2 | Executive Function |
2 | Excitatory Amino Acid Antagonists |
2 | Enzyme Inhibitors |
2 | Electrodes |
2 | Electrocardiography |
2 | Dyskinesias |
2 | Drug Administration Routes |
2 | Dopaminergic Neurons |
2 | Dopamine Agents |
2 | Disruptive, Impulse Control, and Conduct Disorders |
2 | Dependovirus |
2 | DNA Primers |
2 | Cysteine Proteinase Inhibitors |
2 | Cues |
2 | Cross-Cultural Comparison |
2 | Clozapine |
2 | Chromosomes, Human, Pair 8 |
2 | Chromosomes, Human, Pair 6 |
2 | Chromosomes, Human, Pair 2 |
2 | Chromosomes, Human, Pair 17 |
2 | Chromosomes, Human, Pair 10 |
2 | Chorea |
2 | Cholinergic Antagonists |
2 | Child, Preschool |
2 | Cerebrovascular Disorders |
2 | Cerebrospinal Fluid |
2 | Cerebral Infarction |
2 | Cerebral Cortex |
2 | Cerebellar Diseases |
2 | Cell Death |
2 | Cell Culture Techniques |
2 | Cell Count |
2 | Carbazoles |
2 | Bulbar Palsy, Progressive |
2 | Brain-Derived Neurotrophic Factor |
2 | Brain Tissue Transplantation |
2 | Brain Damage, Chronic |
2 | Botulinum Toxins |
2 | Body Mass Index |
2 | Benzhydryl Compounds |
2 | Basic Helix-Loop-Helix Transcription Factors |
2 | Autopsy |
2 | Australia |
2 | Arylamine N-Acetyltransferase |
2 | Apraxias |
2 | Apoptosis |
2 | Aphasia |
2 | Anxiety |
2 | Amino Acid Substitution |
2 | Adrenal Medulla |
2 | Adenosine A2 Receptor Antagonists |
2 | Acoustic Stimulation |
2 | Accidental Falls |
1 | gamma-Aminobutyric Acid |
1 | fms-Like Tyrosine Kinase 3 |
1 | beta 2-Microglobulin |
1 | Writing |
1 | Wolff-Parkinson-White Syndrome |
1 | Welding |
1 | Weights and Measures |
1 | Walking |
1 | Vomiting |
1 | Vitamin D-Binding Protein |
1 | Visual Perception |
1 | Vibration |
1 | Vesicular Transport Proteins |
1 | Verbal Behavior |
1 | Vascular Endothelial Growth Factor A |
1 | Valine |
1 | Urinary Bladder Diseases |
1 | Uric Acid |
1 | Ultraviolet Rays |
1 | Ultrasonography, Doppler, Transcranial |
1 | Ubiquitinated Proteins |
1 | Twins |
1 | Twins, Monozygotic |
1 | Tumor Necrosis Factor-alpha |
1 | Trinucleotide Repeats |
1 | Trinucleotide Repeat Expansion |
1 | Transplants |
1 | Transcutaneous Electric Nerve Stimulation |
1 | Tooth Injuries |
1 | Tomography, Emission-Computed |
1 | Tissue Distribution |
1 | Tiapamil Hydrochloride |
1 | Threonine |
1 | Thalamic Diseases |
1 | Texas |
1 | Tetracyclines |
1 | Telemedicine |
1 | Tea |
1 | Tacrolimus |
1 | TOR Serine-Threonine Kinases |
1 | Sweating |
1 | Sweating Sickness |
1 | Survival Rate |
1 | Suppression, Genetic |
1 | Subacute Sclerosing Panencephalitis |
1 | Stuttering |
1 | Structure-Activity Relationship |
1 | Stroke |
1 | Spiperone |
1 | Spinal Diseases |
1 | Spinal Curvatures |
1 | Spinal Cord Injuries |
1 | Speech Disorders |
1 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
1 | Specimen Handling |
1 | Spasm |
1 | Spain |
1 | Somatoform Disorders |
1 | Solvents |
1 | Social Behavior |
1 | Smoking |
1 | Sleep |
1 | Sleep, REM |
1 | Skin Neoplasms |
1 | Singapore |
1 | Shy-Drager Syndrome |
1 | Shoulder Pain |
1 | Shoulder Joint |
1 | Sexual Dysfunction, Physiological |
1 | Sequence Deletion |
1 | Sensation Disorders |
1 | Self-Help Devices |
1 | Selection Bias |
1 | Seizures, Febrile |
1 | Scoliosis |
1 | Schizophrenia, Paranoid |
1 | Safety |
1 | SSPE Virus |
1 | Riluzole |
1 | Restraint, Physical |
1 | Rest |
1 | Respiratory Tract Diseases |
1 | Respiration Disorders |
1 | Reserpine |
1 | Research Design |
1 | Reoperation |
1 | Remote Consultation |
1 | Regional Blood Flow |
1 | Recurrence |
1 | Receptors, Transferrin |
1 | Receptors, Dopamine D4 |
1 | Receptors, Adenosine A2 |
1 | Reactive Oxygen Species |
1 | Rats |
1 | Radio Waves |
1 | RNA, Untranslated |
1 | RNA, Transfer, Glu |
1 | REM Sleep Behavior Disorder |
1 | Pyrrolidinones |
1 | Pyridones |
1 | Pyridines |
1 | Pulmonary Gas Exchange |
1 | Pulmonary Fibrosis |
1 | Pulmonary Disease, Chronic Obstructive |
1 | PubMed |
1 | Psychomotor Disorders |
1 | Psychomotor Agitation |
1 | Psychometrics |
1 | Psychological Tests |
1 | Psychiatry |
1 | Proto-Oncogene Proteins c-bcl-2 |
1 | Proto-Oncogene Proteins c-akt |
1 | Proteomics |
1 | Proteins |
1 | Protein Precursors |
1 | Protein Folding |
1 | Prostaglandin-Endoperoxide Synthases |
1 | Propylamines |
1 | Propofol |
1 | Program Evaluation |